Found 27 matching trials
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors PHASE1 The proposed clinical study is a Phase 1/2a trial to investigate the safety...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma PHASE2 About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Show More Location
Memorial Sloan Kettering Cancer Center
Treatments Being Tested
Etoposide, carboplatin, ifosfamide Rituximab, Ifosfamide, Etoposide, Carboplatin Rituximab, Ifosfamide, Etoposide, Carboplatin, Stem Cell Collection, Mitoxantrone, Cyclophosphamide and etoposide, Carmustine Learn More & Join Trial
T-lymphocytes CD8+/HLA-DR+ and Acute Rejection After Lung Transplantation NA The objectives of the study is to identify associations between acute rejec...
Show More Location
Assistance Publique Des Hopitaux de Marseille
Learn More & Join Trial
Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC PHASE2 Background:
* Stem cells are immature blood cells that grow in the bone ma...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study NA This single-case exploratory clinical study aims to evaluate the therapeuti...
Show More Location
Multiple Locations
Learn More & Join Trial
Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency PHASE2 Background:
-DOCK8 deficiency is a genetic disorder that affects the immun...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors N/A The purpose of this study is to obtain lymphocyte collections from normal h...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Viromes in Infants Presenting With a Septic Syndrome NA Fever in infants younger than 3 months is a common reason for emergency dep...
Show More Location
Montpellier Hospital University
Learn More & Join Trial
Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells PHASE2 Background:
\- Some cancer treatments collect a patient s own blood cells ...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial